What is Medrio?
Founded in 2005 and headquartered in San Francisco, Medrio provides an integrated eClinical software-as-a-service platform designed to streamline the complexities of clinical trials. By digitizing data collection and management, the company enables research organizations to accelerate study timelines and improve data integrity. Medrio occupies a critical niche in the healthcare technology ecosystem, serving as a bridge between traditional clinical research methodologies and modern, cloud-based digital transformation. Its platform is engineered to support the rigorous demands of pharmaceutical, biotech, and medical device companies, positioning the firm as a vital infrastructure provider in the global life sciences market.
How much funding has Medrio raised?
Medrio has raised a total of $34M across 3 funding rounds:
Private Equity
$2M
Private Equity
$30M
Debt
$2M
Private Equity (2011): $2M, investors not publicly disclosed
Private Equity (2017): $30M led by Questa Capital Management
Debt (2020): $2M supported by PPP
Key Investors in Medrio
Questa Capital Management
Questa Capital invests in innovative healthcare companies that aim to enhance patient experiences, reduce costs, and improve overall population health. They partner with exceptional teams to support the development of next-generation healthcare solutions.
PPP
Public-Private Partnership
Undisclosed Investors
What's next for Medrio?
Following the recent strategic financing, Medrio is well-positioned to deepen its penetration into the enterprise clinical trial market. The company's roadmap likely involves enhancing its SaaS capabilities to address emerging challenges in decentralized clinical trials and real-world evidence generation. By leveraging its established reputation and historical backing, Medrio is poised to expand its footprint, potentially through product innovation or strategic market consolidation. As the industry shifts toward more agile, data-centric research models, Medrio's focus on scalable, user-friendly technology will be instrumental in maintaining its competitive advantage and driving long-term value for its stakeholders.
See full Medrio company page